GENTAMICIN 0.3 % — DIN 02023776
GENTAMICIN (GENTAMICIN SULFATE) : 0.3 % · STERI-MED PHARMA INC. · OINTMENT · wholesale supply in Canada
Health Canada status: APPROVED
What is GENTAMICIN?
GENTAMICIN 0.3 % contains GENTAMICIN (GENTAMICIN SULFATE) : 0.3 %. It is listed in the Health Canada Drug Product Database under DIN 02023776, held by STERI-MED PHARMA INC., supplied as OINTMENT for OPHTHALMIC administration. Health Canada currently lists it as approved, status dated 07-Feb-2025. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A). This DIN is not currently being marketed in Canada, so it is sourced to order where a compliant route exists rather than held in stock.
How much does Gentamicin cost around the world?
Gentamicin is listed on 10 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Austria publishes a KVP (Kassenverkaufspreis); Czechia publishes a max producer price (ex-factory); Greece publishes a producer price (ex-factory). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| South Africa | single exit price | 19 | 22 | ZAR███.██ |
| Saudi Arabia | public | 15 | 16 | SAR███.██ |
| United States | acquisition | 4 | 15 | USD███.██ |
| United Kingdom | hospital | 7 | 7 | GBP███.██ |
| Czechia | max producer price (ex-factory) | 4 | 5 | CZK███.██ |
| Greece | producer price (ex-factory) | 4 | 4 | EUR███.██ |
| Romania | max producer price | 4 | 4 | RON███.██ |
| Austria | KVP (Kassenverkaufspreis) | 3 | 3 | EUR███.██ |
| Iceland | max wholesale | 3 | 3 | ISK███.██ |
| Hungary | producer price (ex-factory) | 2 | 2 | HUF███.██ |
81 pack listings across 65 brand entries and 9 price bases, refreshed 03 Sep 2026. Ranges span every Gentamicin pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Is there a generic Gentamicin in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
16 holders have a Canadian DIN containing Gentamicin, across 22 DINs, of which 0 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| BAUSCH & LOMB CANADA INC. | 2 | 0 | GENTRASUL LIQ 3MG/ML, GENTRASUL OPH OINTMENT 3MG/GM | No marketed DIN |
| HERDT ET CHARTON INC. | 2 | 0 | OCUGRAM LIQ 3MG/ML, OCUGRAM ONT 3MG/GM | No marketed DIN |
| MERCK CANADA INC | 2 | 0 | GARAMYCIN OPHTHALMIC DROPS 0.3%, GARAMYCIN OPHTHALMIC OINTMENT 0.3% | No marketed DIN |
| ODAN LABORATORIES LTD | 2 | 0 | ODAN-GENTAMICIN | No marketed DIN |
| PHARMASCIENCE INC | 2 | 0 | PMS-GENTAMICIN OPHTHALMIC OINTMENT 0.3%, PMS-GENTAMICIN SULFATE OPH DPS 0.3% | No marketed DIN |
| SANDOZ CANADA INCORPORATED | 2 | 0 | SANDOZ GENTAMICIN | No marketed DIN |
| ALCON CANADA INC | 1 | 0 | ALCOMICIN OPH SOL 3MG/ML | No marketed DIN |
| CHAUVIN PHARMACEUTICALS LIMITED | 1 | 0 | MINIMS GENTAMICIN SULFATE 0.3% | No marketed DIN |
| RICHMOND PHARMACEUTICALS INC. | 1 | 0 | R.O.-GENTYCIN | No marketed DIN |
| RIVEX OPHTHALMICS INC. | 1 | 0 | GENTAMICIN SULPHATE 0.3% - LIQ OPH | No marketed DIN |
| STERI-MED PHARMA INC. | 1 | 0 | GENTAMICIN | No marketed DIN |
| TECHNILAB PHARMA INC. | 1 | 0 | GARATEC OPHTHALMIC DPS 5MG/ML | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 0.3 % |
|---|---|
| Dosage form | OINTMENT |
| Route | OPHTHALMIC |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Gentamicin |
|---|---|
| ATC code | S01AA11 |
| AHFS class | 52:04.04 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02023776 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2023776 |
| Brand name | GENTAMICIN |
| Generic / active ingredient | GENTAMICIN (GENTAMICIN SULFATE) : 0.3 % |
| Market authorization holder | STERI-MED PHARMA INC. |
| Health Canada schedule | Prescription |
| ATC code | S01AA11 |
| ATC anatomical main group | S — Sensory organs |
| ATC therapeutic subgroup | S01AA |
| Current status | APPROVED |
| Status date | 07-Feb-2025 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
0 of 22 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| ALCOMICIN OPH SOL 3MG/ML | 3 MG | LIQUID | ALCON CANADA INC | CANCELLED POST MARKET | 00436771 |
| GARAMYCIN OPHTHALMIC DROPS 0.3% | 3 MG | DROPS | MERCK CANADA INC | CANCELLED POST MARKET | 00512192 |
| GARAMYCIN OPHTHALMIC OINTMENT 0.3% | 0.3 % | OINTMENT | MERCK CANADA INC | CANCELLED POST MARKET | 00028339 |
| GARATEC OPHTHALMIC DPS 5MG/ML | 5 MG | DROPS | TECHNILAB PHARMA INC. | CANCELLED POST MARKET | 00880191 |
| GENTACIDIN OPH SOLN 3MG/ML | 3 MG | DROPS | IOLAB PHARMACEUTICALS | CANCELLED POST MARKET | 00810282 |
| GENTACIDIN OPHTHALMIC SOLUTION 3MG/ML | 3 MG | DROPS | CIBA VISION CANADA INC | CANCELLED POST MARKET | 02133245 |
| GENTAMICIN | 0.3 % | SOLUTION | PHARMA STULLN INC. | CANCELLED POST MARKET | 02023822 |
| GENTAMICIN | .3 % | SOLUTION | IVAX PHARMACEUTICALS INCORPORATED | CANCELLED POST MARKET | 02219581 |
| GENTAMICIN SULPHATE 0.3% - LIQ OPH | 3 MG | LIQUID | RIVEX OPHTHALMICS INC. | CANCELLED POST MARKET | 02212927 |
| GENTRASUL LIQ 3MG/ML | 3 MG | DROPS | BAUSCH & LOMB CANADA INC. | CANCELLED POST MARKET | 00772429 |
2 · Same class — other molecules in ATC S01AA
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Erythromycin | ERYMYCIN OPHTHALMIC OINTMENT 5MG/G · ERYTHROMYCIN · ERYTHROMYCIN OPHTHALMIC OINTMENT U.S.P. · ERYTHROMYCIN OPHTHALMIC OINTMENT USP · +5 more | 9 | 3 | Yes |
| Tobramycin | APO-TOBRAMYCIN · PMS-TOBRAMYCIN 0.3% OPHTHALMIC SOLUTION · SANDOZ TOBRAMYCIN · TOBRAMYCIN OPHTHALMIC SOLUTION USP 0.3% · +2 more | 7 | 3 | Yes |
| Combinations Of Different Antibiotics | DIOSPORIN OINTMENT · EUROSPORIN · NEO BACE OPHTHALMIC OINTMENT · NEOSPORIN OPHTHALMIC OINTMENT · +9 more | 14 | 2 | Yes |
| Fusidic Acid | FUCITHALMIC | 2 | 1 | Yes |
| Gentamicin | ALCOMICIN OPH SOL 3MG/ML · GARAMYCIN OPHTHALMIC DROPS 0.3% · GARAMYCIN OPHTHALMIC OINTMENT 0.3% · GARATEC OPHTHALMIC DPS 5MG/ML · +14 more | 22 | 0 | Not in Canada |
| Chloramphenicol | CEBENICOL OPH LIQ 0.4% · CHLORAMPHENICOL · CHLOROMYCETIN OPH ONT 1% · CHLOROMYCETIN OPH SOLN 0.5% · +12 more | 18 | 0 | Not in Canada |
| Framycetin | SOFRAMYCIN EYE DROPS · SOFRAMYCIN EYE DROPS 0.5% · SOFRAMYCIN EYE DROPS 5MG/ML · SOFRAMYCIN EYE ONT 0.5% · +2 more | 6 | 0 | Not in Canada |
| Tetracycline | ACHROMYCIN ONT OPH 1% · TETRACYCLINE 1% OPHTHALMIC OINTMENT | 2 | 0 | Not in Canada |
| Azithromycin | AZASITE | 2 | 0 | Not in Canada |
| Bacitracin | BACIGUENT OPH ONT 500UNIT/GM | 1 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC S01A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| S01AE | Besifloxacin · Ciprofloxacin · Gatifloxacin · Moxifloxacin · Ofloxacin | 25 | 12 |
| S01AD | Ganciclovir · Idoxuridine · Trifluridine | 6 | 1 |
| S01AB | Sulfacetamide · Sulfacetamide, Combinations | 14 | 0 |
| S01AX | Norfloxacin · Sodium Borate | 15 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is GENTAMICIN called?
The same molecule, Gentamicin, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| GENTACIN | Latin | Saudi Arabia |
| GENTAMICIN WZF POLFA | Latin | Czechia |
| Micro-Gentamicin | Latin | South Africa |
| Septopal Beads & Chains | Latin | South Africa |
| BAGENTA | Latin | Saudi Arabia |
| GARAMYCIN SCHWAMM | Latin | Czechia |
| Genta | Latin | Iceland |
| Genta vet. | Latin | Iceland |
| Genta-Equine | Latin | Iceland |
| GENTAMICIN LEK | Latin | Czechia |
| GENTAMICIN POLPHARMA | Latin | Czechia |
| Gentax Augensalbe | Latin | Austria |
| Refobacin Creme | Latin | Austria |
| Septopal Minichain | Latin | South Africa |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
How can I get it?
This product is approved by Health Canada but not yet marketed in Canada, so there is no Canadian supply to draw on today. Nexara can tell you whether it has been launched, and can look at supply from other markets where a Canadian pack is not required or where importation is permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.